Logo image of NRN.CA

NORTHERN SHIELD RESOURCES IN (NRN.CA) Stock Fundamental Analysis

TSX-V:NRN - TSX Venture Exchange - CA6657203064 - Common Stock - Currency: CAD

0.08  +0.01 (+14.29%)

Fundamental Rating

1

Overall NRN gets a fundamental rating of 1 out of 10. We evaluated NRN against 802 industry peers in the Metals & Mining industry. While NRN seems to be doing ok healthwise, there are quite some concerns on its profitability. NRN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

NRN had negative earnings in the past year.
NRN had a positive operating cash flow in the past year.
NRN had negative earnings in each of the past 5 years.
In the past 5 years NRN reported 4 times negative operating cash flow.
NRN.CA Yearly Net Income VS EBIT VS OCF VS FCFNRN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1M -2M -3M

1.2 Ratios

With a Return On Assets value of -107.15%, NRN is not doing good in the industry: 75.19% of the companies in the same industry are doing better.
With a Return On Equity value of -138.38%, NRN is not doing good in the industry: 69.08% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -107.15%
ROE -138.38%
ROIC N/A
ROA(3y)-44.73%
ROA(5y)-29.8%
ROE(3y)-56.39%
ROE(5y)-37.05%
ROIC(3y)N/A
ROIC(5y)N/A
NRN.CA Yearly ROA, ROE, ROICNRN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800 -1K

1.3 Margins

NRN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NRN.CA Yearly Profit, Operating, Gross MarginsNRN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

4

2. Health

2.1 Basic Checks

NRN has more shares outstanding than it did 1 year ago.
NRN has more shares outstanding than it did 5 years ago.
There is no outstanding debt for NRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NRN.CA Yearly Shares OutstandingNRN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NRN.CA Yearly Total Debt VS Total AssetsNRN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

NRN has an Altman-Z score of -9.36. This is a bad value and indicates that NRN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -9.36, NRN is doing worse than 70.07% of the companies in the same industry.
NRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -9.36
ROIC/WACCN/A
WACCN/A
NRN.CA Yearly LT Debt VS Equity VS FCFNRN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

2.3 Liquidity

NRN has a Current Ratio of 0.75. This is a bad value and indicates that NRN is not financially healthy enough and could expect problems in meeting its short term obligations.
NRN has a worse Current ratio (0.75) than 63.34% of its industry peers.
A Quick Ratio of 0.75 indicates that NRN may have some problems paying its short term obligations.
NRN's Quick ratio of 0.75 is on the low side compared to the rest of the industry. NRN is outperformed by 61.22% of its industry peers.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.75
NRN.CA Yearly Current Assets VS Current LiabilitesNRN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

0

3. Growth

3.1 Past

The earnings per share for NRN have decreased strongly by -197.66% in the last year.
EPS 1Y (TTM)-197.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.27%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NRN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NRN.CA Price Earnings VS Forward Price EarningsNRN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NRN.CA Per share dataNRN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

NRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NORTHERN SHIELD RESOURCES IN

TSX-V:NRN (5/9/2025, 7:00:00 PM)

0.08

+0.01 (+14.29%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)04-23 2025-04-23
Earnings (Next)05-29 2025-05-29
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners14.96%
Ins Owner ChangeN/A
Market Cap7.99M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF 76.73
P/B 3.47
P/tB 3.47
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFY1.3%
SpS0
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -107.15%
ROE -138.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-44.73%
ROA(5y)-29.8%
ROE(3y)-56.39%
ROE(5y)-37.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10600%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.75
Altman-Z -9.36
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)7642.4%
Cap/Depr(5y)7099.56%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-197.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.27%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y70.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y119.43%
OCF growth 3YN/A
OCF growth 5YN/A